Predicting MCI Outcome with Clinically Available MRI and CSF Biomarkers

被引：0
|
作者：
Heister, David S.
Brewer, James B.
Magda, Sebastian
Blennow, Kaj
McEvoy, Linda K.
机构：
来源：
ANNALS OF NEUROLOGY | 2011年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Predicting MCI outcome with clinically available MRI and CSF biomarkers
    Heister, D.
    Brewer, J. B.
    Magda, S.
    Blennow, K.
    McEvoy, L. K.
    NEUROLOGY, 2011, 77 (17) : 1619 - 1628
  • [2] MRI and CSF biomarkers in normal, MCI, and AD subjects Predicting future clinical change
    Vemuri, P.
    Wiste, H. J.
    Weigand, S. D.
    Shaw, L. M.
    Trojanowski, J. Q.
    Weiner, M. W.
    Knopman, D. S.
    Petersen, R. C.
    Jack, C. R.
    NEUROLOGY, 2009, 73 (04) : 294 - 301
  • [3] Serial MRI and CSF biomarkers in normal aging, MCI, and AD
    Vemuri, P.
    Wiste, H. J.
    Weigand, S. D.
    Knopman, D. S.
    Trojanowski, J. Q.
    Shaw, L. M.
    Bernstein, M. A.
    Aisen, P. S.
    Weiner, M.
    Petersen, R. C.
    Jack, C. R., Jr.
    NEUROLOGY, 2010, 75 (02) : 143 - 151
  • [4] Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
    Vos, Stephanie
    van Rossum, Ineke
    Burns, Leah
    Knol, Dirk
    Scheltens, Philip
    Soininen, Hilkka
    Wahlund, Lars-Olof
    Hampel, Harald
    Tsolaki, Magda
    Minthon, Lennart
    Handels, Ron
    L'Italien, Gilbert
    van der Flier, Wiesje
    Aalten, Pauline
    Teunissen, Charlotte
    Barkhof, Frederik
    Blennow, Kaj
    Wolz, Robin
    Rueckert, Daniel
    Verhey, Frans
    Visser, Pieter Jelle
    NEUROBIOLOGY OF AGING, 2012, 33 (10) : 2272 - 2281
  • [5] Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
    Davatzikos, Christos
    Bhatt, Priyanka
    Shaw, Leslie M.
    Batmanghelich, Kayhan N.
    Trojanowski, John Q.
    NEUROBIOLOGY OF AGING, 2011, 32 (12) : 2322.e19 - 2322.e27
  • [6] CSF Biomarkers and Amyloid PET in MCI
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 18N - 18N
  • [7] MRI and CSF biomarkers in normal, MCI, and AD subjects Diagnostic discrimination and cognitive correlations
    Vemuri, P.
    Wiste, H. J.
    Weigand, S. D.
    Shaw, L. M.
    Trojanowski, J. Q.
    Weiner, M. W.
    Knopman, D. S.
    Petersen, R. C.
    Jack, C. R., Jr.
    NEUROLOGY, 2009, 73 (04) : 287 - 293
  • [8] Biomarkers predicting treatment outcome in depression: what is clinically significant?
    Uher, Rudolf
    Tansey, Katherine E.
    Malki, Karim
    Perlis, Roy H.
    PHARMACOGENOMICS, 2012, 13 (02) : 233 - 240
  • [9] CSF biomarkers to predict incipient AD in MCI cases
    Blennow, K
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 118 - 118
  • [10] Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial
    L. K. Joachim
    L. Frölich
    E. Rüther
    J. Wiltfang
    W. Maier
    J. Kornhuber
    C. Bauer
    I. Heuser
    Oliver Peters
    The Journal of Prevention of Alzheimer's Disease, 2018, 5 : 202 - 206
12345